Jury rules for KCI in NPWT spat with Smith & Nephew

March 10, 2010 by MassDevice staff

A Texas jury ruled that Smith & Nephew's Renasys-F negative-pressure wound therapy infringes a pair of patents licensed to Kinetic Concepts Inc.

SNN, KCI logos

A Texas jury handed a win to Kinetic Concepts Inc. (NYSE:KCI) in its wound care war with Smith & Nephew (NYSE:SNN), ruling that the British medical products conglomerate infringed a pair of KCI-licensed patents with its Renasys-F negative-pressure wound therapy.

The jury in the U.S. District Court for Western Texas decided that the Smith & Nephew product violates a pair of patents owned by Wake Forest University and licensed to KCI, which sued Smith & Nephew for patent infringement in 2008. The jury found that KCI showed it lost about $900,000 in profits and about $143,000 in lost royalties due to the infringement, which also cost Wake Forest roughly $186,000 in lost royalties, according to court documents.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.